Job Description
Responsibilities
- Build, manage and develop relationships with target urologists, uro‑oncologists and MDT leads across approximately 8 private specialist centres nationally.
- Secure formulary inclusion, prescriber engagement and patient access pathways within each target account.
- Navigate private hospital procurement, pharmacy and governance processes to enable product availability at launch.
- Identify and resolve access barriers at account level — including PMI prior authorisation requirements, pharmacy stocking and clinical governance approvals.
- Maintain accurate and current account plans for each target centre with clear access milestones, stakeholder maps and activity records.
- Support the Portfolio Lead in insurer engagement — providing field intelligence on insurer coverage decisions, prior authorisation outcomes and patient funding challenges.
- Act as the field interface between prescribing urologists and insurer medical teams where clinical justification or appeals processes are required.
- Gather and report real‑world coverage data to inform the ongoing insurer access strategy.
- Track and report account‑level sales activity, patient starts, insurer coverage outcomes and access milestones.
- Contribute to quarterly business reviews with accurate field intelligence, account‑level analysis and market insight.
- Manage territory budget (meetings, materials, travel) within agreed parameters and compliance requirements.
- Identify, develop and maintain relationships with key opinion leaders in private urology and uro‑oncology.
- Support clinical education activities, advisory boards and congress engagement in partnership with the MSL.
- Provide field‑based intelligence on clinical sentiment, competitive activity and evolving treatment pathways.
Qualifications
- Significant experience in a KAM or specialist sales role within oncology, haematology or a high‑value specialty therapy area.
- Proven track record of navigating private market access — PMI reimbursement, private hospital networks or high‑cost therapy commissioning pathways.
- Experience working with high‑cost, low‑volume specialty products where access complexity is the primary commercial challenge.
- Strong commercial and financial acumen — able to articulate budget impact arguments and value propositions to clinical and non‑clinical stakeholders.
- Self‑starter with the ability to operate independently in a lean team without traditional sales infrastructure.
- Excellent relationship management skills — credible and confident with senior clinicians, medical directors and insurer personnel.
- Full UK driving licence.
- Direct experience in bladder cancer, urological cancers or intravesical therapy — existing relationships with UK private urology centres an advantage.
- Experience in CAR‑T, cell and gene therapy or other ATMP commercial environments.
- Experience launching a new product in the UK private market from pre‑launch through to established access.
- Existing network across London private oncology/urology (Royal Marsden, HCA, LOC/Harley Street, The Christie).
This Role Offers
- The opportunity to be the commercial lead on the UK private market launch of a first‑in‑class intravesical gene therapy — a genuinely career‑defining assignment.
- A focused, high‑value account universe — quality over quantity, strategic over transactional.
- Close working relationship with a senior commercial team and direct exposure to launch strategy.
- Real autonomy and ownership in a lean, entrepreneurial environment.
